Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ASP2151

Known as: ASP 2151 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
&NA; The antiherpetic drugs acyclovir (ACV, valaciclovir) and penciclovir (famciclovir) are phosphorylated by viral thymidine… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2013
2013
ASP2151 (amenamevir) is a helicase-primase complex inhibitor with antiviral activity against herpes simplex virus HSV-1, HSV-2… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 3
Review
2013
Review
2013
Varicella-zoster virus (VZV) causes two distinct diseases, varicella (chickenpox) and shingles (herpes zoster). Chickenpox occurs… Expand
Highly Cited
2012
Highly Cited
2012
BACKGROUND Current therapies for genital herpes have only partial efficacy. Helicase-primase inhibitors are novel, potent… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
2012
2012
ABSTRACT ASP2151 (amenamevir) is a helicase-primase inhibitor against herpes simplex virus 1 (HSV-1), HSV-2, and varicella zoster… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2012
2012
ASP2151 was developed as a novel inhibitor of herpes simplex virus (HSV) and varicella-zoster virus helicase-primase. The anti… Expand
2012
2012
ABSTRACT ASP2151 (amenamevir) is a helicase-primase inhibitor against herpes simplex virus type 1 (HSV-1), HSV-2, and varicella… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
2012
2012
ASP2151 is an antiherpes agent targeting the helicase-primase complex of herpes simplex virus (HSV)-1, HSV-2, and varicella… Expand
2011
2011
ASP2151 is a herpesvirus helicase-primase inhibitor with antiviral activity against varicella zoster virus and herpes simplex… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 2
  • figure 3
Highly Cited
2010
Highly Cited
2010
OBJECTIVES To evaluate and describe the anti-herpesvirus effect of ASP2151, amenamevir, a novel non-nucleoside oxadiazolylphenyl… Expand